Tofidence
Payments companies reported to CMS as associated with Tofidence. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Tofidence, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Tofidence
These are the largest totals companies reported as associated with Tofidence. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Sergio Schwartzman | New York, NY | Rheumatology | $3,741.50 |
| John Tesser | Phoenix, AZ | Rheumatology | $2,044.00 |
| Monica Schwartzman | New York, NY | Rheumatology | $1,496.00 |
| Alvin Wells | Destin, FL | Rheumatology | $954.00 |
| Leyka Barbosa | Dallas, TX | Rheumatology | $109.96 |
| Ara Dikranian | San Diego, CA | Rheumatology | $62.50 |
| Mona Amin | Glendale, AZ | Rheumatology | $62.50 |
| Ami Ben-Artzi | Del Mar, CA | Rheumatology | $44.12 |
| Peter Hennis | Casa Grande, AZ | Gerontology (Nurse Practitioner) | $21.53 |
| Zachary Fellows | Carlsbad, CA | Rheumatology | $17.92 |
Prescribed Tofidence?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.